Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO9A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | NFAM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ATP10B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | CST1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | CWF19L2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | DRAP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | FLYWCH2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | NOXO1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | LILRA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | RP11-637O19.3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |